Laboratory-Confirmed Influenza B Infection in Immunized Long-Term Care Facility Residents Receiving Oseltamivir Prophylaxis in Ontario

We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection control and hospital epidemiology 2013-11, Vol.34 (11), p.1225-1228
Hauptverfasser:	Winter, Anne-Luise, Peci, Adriana, Eshaghi, AliReza, Baird, Michelle, Memari, Nader, Kristjanson, Erik, Balogun, Elizabeth, Higgins, Rachel R., Li, Aimin, Farrell, David J., Gubbay, Jonathan B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - therapeutic use Antivirals Biological and medical sciences Concise Communication Disease Outbreaks Human viral diseases Humans Infections Infectious diseases Influenza A virus Influenza B virus - drug effects Influenza B virus - genetics Influenza B virus - isolation & purification Influenza Vaccines Influenza, Human - drug therapy Influenza, Human - epidemiology Influenza, Human - prevention & control Influenza, Human - virology Inhibitory Concentration 50 Long-Term Care Medical sciences Microbial Sensitivity Tests Microbiology Middle Aged Miscellaneous Nucleotides Nursing Older adults Ontario - epidemiology Oseltamivir - therapeutic use Pharmacology. Drug treatments Phylogeny Post-Exposure Prophylaxis Public health Public health. Hygiene Public health. Hygiene-occupational medicine Specimens Vaccination Viral diseases Viral diseases of the respiratory system and ent viral diseases Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them had resistance identified.
ISSN:	0899-823X 1559-6834
DOI:	10.1086/673455